4//SEC Filing
BELVIN MARCIA 4
Accession 0001610717-25-000082
CIK 0001501989other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:31 PM ET
Size
4.7 KB
Accession
0001610717-25-000082
Insider Transaction Report
Form 4
BELVIN MARCIA
SVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-03-18$0.60/sh−19,512$11,688→ 248,636 total
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- [F2]Includes 158,958 RSUs.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001970752
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:31 PM ET
- Size
- 4.7 KB